Mettler-Toledo International (NYSE:MTD) Research Coverage Started at Rothschild & Co Redburn

Rothschild & Co Redburn began coverage on shares of Mettler-Toledo International (NYSE:MTD) in a research note issued to investors on Wednesday morning, Marketbeat Ratings reports. The brokerage issued a sell rating and a $1,200.00 target price on the medical instruments supplier’s stock.

A number of other equities analysts have also recently weighed in on MTD. Wolfe Research initiated coverage on shares of Mettler-Toledo International in a research report on Tuesday, June 2nd. They set a “peer perform” rating on the stock. Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating on the stock in a research note on Monday, May 11th. Morgan Stanley lifted their target price on Mettler-Toledo International from $1,275.00 to $1,450.00 and gave the stock an “equal weight” rating in a report on Tuesday, August 4th. Royal Bank Of Canada initiated coverage on Mettler-Toledo International in a research note on Tuesday. They issued a “sector perform” rating and a $1,515.00 target price for the company. Finally, JPMorgan Chase & Co. lowered their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating for the company in a report on Monday, May 11th. Six analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $1,445.31.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock opened at $1,344.87 on Wednesday. The firm has a market capitalization of $26.95 billion, a P/E ratio of 30.27, a PEG ratio of 2.79 and a beta of 1.22. Mettler-Toledo International has a 1 year low of $1,023.05 and a 1 year high of $1,525.17. The business has a 50-day moving average of $1,361.63 and a 200-day moving average of $1,274.73. The company has a current ratio of 1.12, a quick ratio of 0.78 and a debt-to-equity ratio of 159.45.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share for the quarter, beating analysts’ consensus estimates of $10.78 by $0.68. Mettler-Toledo International had a net margin of 21.91% and a negative return on equity of 1,212.14%. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period last year, the company posted $10.09 EPS. Mettler-Toledo International’s revenue for the quarter was up 4.5% on a year-over-year basis. On average, equities analysts anticipate that Mettler-Toledo International will post 47.35 EPS for the current year.

Insider Activity at Mettler-Toledo International

In other news, insider Gerry Keller sold 240 shares of the stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total transaction of $342,513.60. Following the completion of the sale, the insider owned 259 shares of the company’s stock, valued at $369,629.26. This represents a 48.10% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO Shawn Vadala sold 2,240 shares of the firm’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $1,432.00, for a total transaction of $3,207,680.00. Following the sale, the chief financial officer owned 5,579 shares in the company, valued at approximately $7,989,128. The trade was a 28.65% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 4,254 shares of company stock worth $6,092,712 over the last ninety days. 0.71% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Corient Private Wealth LP grew its holdings in shares of Mettler-Toledo International by 421.7% during the second quarter. Corient Private Wealth LP now owns 26,147 shares of the medical instruments supplier’s stock worth $33,402,000 after buying an additional 21,135 shares in the last quarter. Principia Wealth Advisory LLC raised its position in Mettler-Toledo International by 2,050.0% in the 2nd quarter. Principia Wealth Advisory LLC now owns 43 shares of the medical instruments supplier’s stock valued at $55,000 after buying an additional 41 shares during the last quarter. Amundi lifted its stake in Mettler-Toledo International by 40.7% in the 2nd quarter. Amundi now owns 240,640 shares of the medical instruments supplier’s stock valued at $307,420,000 after acquiring an additional 69,620 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in Mettler-Toledo International in the 2nd quarter valued at approximately $16,366,000. Finally, California State Teachers Retirement System boosted its position in Mettler-Toledo International by 114,807.7% during the 2nd quarter. California State Teachers Retirement System now owns 35,100,865 shares of the medical instruments supplier’s stock worth $44,841,706,000 after acquiring an additional 35,070,318 shares during the last quarter. 95.07% of the stock is owned by institutional investors and hedge funds.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.